AI assistant
Sending…
ANI PHARMACEUTICALS INC — Director's Dealing 2025
Sep 4, 2025
31676_dirs_2025-09-04_523f86cf-cce4-48dc-b02c-45bb8224efef.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2025-09-03
Reporting Person: Pera Antonio R (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-09-03 | Common Stock | S | 7292 | $94.94 | Disposed | 22660 | Direct |
More from ANI PHARMACEUTICALS INC
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
May 8
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 4
Investor Presentation
2026
Mar 3